Matteo Casenghi Selected Research

Matteo Casenghi Research Topics

4	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 01/2019
4	Heart Failure 01/2022 - 06/2014
3	Myocardial Infarction 04/2024 - 01/2021
3	Aortic Valve Insufficiency (Aortic Regurgitation) 11/2022 - 01/2021
2	Patent Foramen Ovale 01/2022 - 01/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 06/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2021
2	Death (Near-Death Experience) 10/2021 - 01/2021
2	Bicuspid Aortic Valve Disease 01/2021 - 01/2021
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2021 - 11/2018
2	Stroke (Strokes) 01/2019 - 01/2018
1	Hemorrhage 04/2024
1	Acute Kidney Injury (Acute Renal Failure) 04/2024
1	Hypersensitivity (Allergy) 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022
1	Thrombosis (Thrombus) 10/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Ischemia 10/2021
1	Diabetes Mellitus 10/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Hyperplasia 06/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2018
1	Systolic Heart Failure 01/2015
1	Atrial Fibrillation 01/2015

2	Sirolimus (Rapamycin)FDA Link 10/2021 - 06/2019
2	omega-Chloroacetophenone (Mace)IBA 10/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 11/2018 - 01/2015
1	CholesterolIBA 04/2024
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022
1	NickelIBA 01/2022
1	AlloysIBA 01/2022
1	nitinolIBA 01/2022
1	Insulin (Novolin)FDA Link 10/2021
1	CalciumIBA 01/2021
1	Everolimus FDA Link 06/2019

8	Transcatheter Aortic Valve Replacement 11/2022 - 01/2018
2	Percutaneous Coronary Intervention 04/2024 - 10/2021
2	Prostheses and Implants (Prosthesis) 01/2022 - 01/2021
2	Stents 10/2021 - 06/2019
1	Bioprosthesis 01/2022
1	Sutures (Suture) 01/2022
1	Heart Transplantation (Grafting, Heart) 11/2018
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2018
1	Polypharmacy 06/2014